{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T13:10:03Z","timestamp":1789132203574,"version":"build-2803163510"},"reference-count":32,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T00:00:00Z","timestamp":1758844800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82273723"],"award-info":[{"award-number":["82273723"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011176","name":"Peking Union Medical College","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011176","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100019018","name":"Chinese Academy of Medical Sciences Innovation Fund for Medical Sciences","doi-asserted-by":"publisher","award":["2021-I2M-1-004"],"award-info":[{"award-number":["2021-I2M-1-004"]}],"id":[{"id":"10.13039\/501100019018","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the National Cancer Center"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.jncc.2025.07.003","type":"journal-article","created":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T22:26:19Z","timestamp":1759011979000},"page":"586-592","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Ten-year evaluation of HPV vaccine influence on non-vaccine-type-related cervical infections and precancers in Chinese females: follow-up from a randomized control trial"],"prefix":"10.1016","volume":"5","author":[{"given":"Tianmeng","family":"Wen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changchang","family":"Dun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shangying","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qinjing","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9294-0005","authenticated-orcid":false,"given":"Fanghui","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jncc.2025.07.003_bib0001","unstructured":"International Agency for Research on Cancer. Global Cancer Observatory: Cancer Today. Accessed 18 July 2024. https:\/\/gco.iarc.who.int\/today."},{"issue":"4","key":"10.1016\/j.jncc.2025.07.003_bib0002","doi-asserted-by":"crossref","first-page":"pky045","DOI":"10.1093\/jncics\/pky045","article-title":"Burden of human papillomavirus (HPV)-related cancers attributable to HPVs 6\/11\/16\/18\/31\/33\/45\/52 and 58","volume":"2","author":"de Sanjos\u00e9","year":"2018","journal-title":"JNCI Cancer Spectr"},{"key":"10.1016\/j.jncc.2025.07.003_bib0003","unstructured":"World Health Organization. Global strategy to accelerate the elimination of cervical cancer as a public health problem. Accessed 10 June 2025. https:\/\/www.who.int\/publications\/i\/item\/9789240014107."},{"key":"10.1016\/j.jncc.2025.07.003_bib0004","unstructured":"World Health Organization. Global HPV programme status. Accessed 26 August 2025. https:\/\/app.powerbi.com\/view?r=eyJrIjoiNDIxZTFkZGUtMDQ1Ny00MDZkLThiZDktYWFlYTdkOGU2NDcwIiwidCI6ImY2MTBjMGI3LWJkMjQtNGIzOS04MTBiLTNkYzI4MGFmYjU5MCIsImMiOjh9."},{"key":"10.1016\/j.jncc.2025.07.003_bib0005","unstructured":"VIEW-hub. Current HPV Vaccine Intro Status. Accessed 5 August 2025. https:\/\/view-hub.org\/vaccine\/hpv."},{"issue":"12","key":"10.1016\/j.jncc.2025.07.003_bib0006","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1086\/657321","article-title":"Cervical human papillomavirus prevalence in 5 continents: meta-analysis of 1 million women with normal cytological findings","volume":"202","author":"Bruni","year":"2010","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jncc.2025.07.003_bib0007","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1186\/1479-5876-8-105","article-title":"HPV vaccine: an overview of immune response, clinical protection, and new approaches for the future","volume":"8","author":"Mariani","year":"2010","journal-title":"J Transl Med"},{"issue":"5","key":"10.1016\/j.jncc.2025.07.003_bib0008","doi-asserted-by":"crossref","first-page":"e103","DOI":"10.1093\/cid\/ciaa1770","article-title":"Population impact of girls-only human papillomavirus 16\/18 vaccination in the Netherlands: cross-protective and second-order herd effects","volume":"72","author":"Hoes","year":"2021","journal-title":"Clin Infect Dis"},{"issue":"2","key":"10.1016\/j.jncc.2025.07.003_bib0009","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1093\/infdis\/jix582","article-title":"Bivalent vaccine effectiveness against type-specific HPV positivity: evidence for cross-protection against oncogenic types among Dutch STI clinic visitors","volume":"217","author":"Woestenberg","year":"2018","journal-title":"J Infect Dis"},{"issue":"9807","key":"10.1016\/j.jncc.2025.07.003_bib0010","doi-asserted-by":"crossref","first-page":"1962","DOI":"10.1016\/S0140-6736(10)62225-8","article-title":"Serotype replacement in disease after pneumococcal vaccination","volume":"378","author":"Weinberger","year":"2011","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.jncc.2025.07.003_bib0011","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1093\/aje\/154.1.85","article-title":"Interpreting results from trials of pneumococcal conjugate vaccines: a statistical test for detecting vaccine-induced increases in carriage of nonvaccine serotypes","volume":"154","author":"Lipsitch","year":"2001","journal-title":"Am J Epidemiol"},{"issue":"7","key":"10.1016\/j.jncc.2025.07.003_bib0012","doi-asserted-by":"crossref","first-page":"djw300","DOI":"10.1093\/jnci\/djw300","article-title":"Evaluation of type replacement following HPV16\/18 vaccination: pooled analysis of two randomized trials","volume":"109","author":"Tota","year":"2017","journal-title":"J Natl Cancer Inst"},{"issue":"7\u20138","key":"10.1016\/j.jncc.2025.07.003_bib0013","doi-asserted-by":"crossref","first-page":"1962","DOI":"10.1080\/21645515.2018.1564438","article-title":"Evidence for cross-protection but not type-replacement over the 11 years after human papillomavirus vaccine introduction","volume":"15","author":"Covert","year":"2019","journal-title":"Hum Vaccin immunothera"},{"issue":"1","key":"10.1016\/j.jncc.2025.07.003_bib0014","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/s12879-018-2945-8","article-title":"Monitoring vaccine and non-vaccine HPV type prevalence in the post-vaccination era in women living in the Basilicata region, Italy","volume":"18","author":"Carozzi","year":"2018","journal-title":"BMC Infect Dis"},{"issue":"12","key":"10.1016\/j.jncc.2025.07.003_bib0015","doi-asserted-by":"crossref","first-page":"2491","DOI":"10.1002\/ijc.31281","article-title":"Evaluation of HPV type-replacement in unvaccinated and vaccinated adolescent females-post-hoc analysis of a community-randomized clinical trial (II)","volume":"142","author":"Gray","year":"2018","journal-title":"Int J Cancer"},{"issue":"8","key":"10.1016\/j.jncc.2025.07.003_bib0016","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1093\/infdis\/jis494","article-title":"Reevaluation of epidemiological data demonstrates that it is consistent with cross-immunity among human papillomavirus types","volume":"206","author":"Durham","year":"2012","journal-title":"J Infect Dis"},{"issue":"10","key":"10.1016\/j.jncc.2025.07.003_bib0017","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.3201\/eid2210.160675","article-title":"Population-level effects of human papillomavirus vaccination programs on infections with nonvaccine genotypes","volume":"22","author":"Mesher","year":"2016","journal-title":"Emerg Infect Dis"},{"issue":"4","key":"10.1016\/j.jncc.2025.07.003_bib0018","doi-asserted-by":"crossref","first-page":"757","DOI":"10.3390\/v14040757","article-title":"Effects of the prophylactic HPV vaccines on HPV type prevalence and cervical pathology","volume":"14","author":"Hampson","year":"2022","journal-title":"Viruses"},{"issue":"11","key":"10.1016\/j.jncc.2025.07.003_bib0019","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1016\/j.chom.2023.10.001","article-title":"Ecological diversity profiles of non-vaccine-targeted HPVs after gender-based community vaccination efforts","volume":"31","author":"Pimenoff","year":"2023","journal-title":"Cell Host Microbe"},{"issue":"3","key":"10.1016\/j.jncc.2025.07.003_bib0020","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1093\/infdis\/jiaa032","article-title":"Human papillomavirus genotype replacement: still too early to tell?","volume":"224","author":"Man","year":"2021","journal-title":"J Infect Dis"},{"issue":"7","key":"10.1016\/j.jncc.2025.07.003_bib0021","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1016\/S1470-2045(22)00291-1","article-title":"Precancerous cervical lesions caused by non-vaccine-preventable HPV types after vaccination with the bivalent AS04-adjuvanted HPV vaccine: an analysis of the long-term follow-up study from the randomised Costa Rica HPV Vaccine Trial","volume":"23","author":"Shing","year":"2022","journal-title":"Lancet Oncol"},{"issue":"12","key":"10.1016\/j.jncc.2025.07.003_bib0022","doi-asserted-by":"crossref","first-page":"2898","DOI":"10.1002\/ijc.25630","article-title":"Predicting the progression of cervical precursor lesions by human papillomavirus genotyping: a prospective cohort study","volume":"128","author":"Matsumoto","year":"2011","journal-title":"Int J Cancer"},{"issue":"14","key":"10.1016\/j.jncc.2025.07.003_bib0023","doi-asserted-by":"crossref","first-page":"6195","DOI":"10.1002\/cam4.2399","article-title":"Efficacy, immunogenicity and safety of the AS04-HPV-16\/18 vaccine in Chinese women aged 18-25 years: end-of-study results from a phase II\/III, randomised, controlled trial","volume":"8","author":"Zhu","year":"2019","journal-title":"Cancer Med"},{"issue":"4","key":"10.1016\/j.jncc.2025.07.003_bib0024","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1111\/ajco.13833","article-title":"Safety of AS04-HPV-16\/18 vaccine in Chinese women aged 26 years and older and long-term protective effect in women vaccinated at age 18-25 years: a 10-year follow-up study","volume":"19","author":"Zhao","year":"2023","journal-title":"Asia Pac J Clin Oncol"},{"issue":"6","key":"10.1016\/j.jncc.2025.07.003_bib0025","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1002\/sim.1039","article-title":"Statistical approaches to establishing vaccine safety","volume":"21","author":"Dragalin","year":"2002","journal-title":"Stat Med"},{"issue":"4","key":"10.1016\/j.jncc.2025.07.003_bib0026","doi-asserted-by":"crossref","first-page":"e30","DOI":"10.3802\/jgo.2017.28.e30","article-title":"High-risk human papillomavirus genotype distribution and attribution to cervical cancer and precancerous lesions in a rural Chinese population","volume":"28","author":"Zhao","year":"2017","journal-title":"J Gynecol Oncol"},{"issue":"11","key":"10.1016\/j.jncc.2025.07.003_bib0027","doi-asserted-by":"crossref","first-page":"2606","DOI":"10.1002\/ijc.30375","article-title":"A cohort study of cervical screening using partial HPV typing and cytology triage","volume":"139","author":"Schiffman","year":"2016","journal-title":"Int J Cancer"},{"issue":"7","key":"10.1016\/j.jncc.2025.07.003_bib0028","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1086\/597307","article-title":"The impact of quadrivalent human papillomavirus (HPV; types 6, 11, 16, and 18) L1 virus-like particle vaccine on infection and disease due to oncogenic nonvaccine HPV types in generally HPV-naive women aged 16-26 years","volume":"199","author":"Brown","year":"2009","journal-title":"J Infect Dis"},{"issue":"4","key":"10.1016\/j.jncc.2025.07.003_bib0029","doi-asserted-by":"crossref","first-page":"217","DOI":"10.2165\/11591760-000000000-00000","article-title":"Development of an AS04-adjuvanted HPV vaccine with the adjuvant system approach","volume":"25","author":"Gar\u00e7on","year":"2011","journal-title":"BioDrugs"},{"issue":"1","key":"10.1016\/j.jncc.2025.07.003_bib0030","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/S1470-2045(11)70287-X","article-title":"Cross-protective efficacy of HPV-16\/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by non-vaccine oncogenic HPV types: 4-year end-of-study analysis of the randomised, double-blind PATRICIA trial","volume":"13","author":"Wheeler","year":"2012","journal-title":"Lancet Oncol"},{"issue":"1","key":"10.1016\/j.jncc.2025.07.003_bib0031","doi-asserted-by":"crossref","DOI":"10.1080\/22221751.2023.2176009","article-title":"Cervical HPV infection in Guangzhou, China: an epidemiological study of 198,111 women from 2015 to 2021","volume":"12","author":"Yang","year":"2023","journal-title":"Emerg Microbes Infect"},{"key":"10.1016\/j.jncc.2025.07.003_bib0032","article-title":"Epidemiology and burden of human papillomavirus and related diseases, molecular pathogenesis, and vaccine evaluation","volume":"8","author":"Kombe Kombe","year":"2020","journal-title":"Front Public Health"}],"container-title":["Journal of the National Cancer Center"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2667005425001103?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2667005425001103?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T10:14:40Z","timestamp":1778926480000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2667005425001103"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":32,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["S2667005425001103"],"URL":"https:\/\/doi.org\/10.1016\/j.jncc.2025.07.003","relation":{},"ISSN":["2667-0054"],"issn-type":[{"value":"2667-0054","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ten-year evaluation of HPV vaccine influence on non-vaccine-type-related cervical infections and precancers in Chinese females: follow-up from a randomized control trial","name":"articletitle","label":"Article Title"},{"value":"Journal of the National Cancer Center","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jncc.2025.07.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Chinese National Cancer Center. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}